Published in Cancer Epidemiol Biomarkers Prev on April 01, 2013
Personal history of prostate cancer and increased risk of incident melanoma in the United States. J Clin Oncol (2013) 0.83
Activation of the Mitochondrial Fragmentation Protein DRP1 Correlates with BRAF(V600E) Melanoma. J Invest Dermatol (2015) 0.79
Current Data on Risk Factor Estimates Does Not Explain the Difference in Rates of Melanoma between Hispanics and Non-Hispanic Whites. J Skin Cancer (2016) 0.78
CXCR4 pathway associated with family history of melanoma. Cancer Causes Control (2013) 0.76
Correlation between High Endothelial Vessels and Histopathological Features of Different Pigmented Lesions. Curr Health Sci J (2013) 0.75
Recurrence of Dysplastic Nevi Is Strongly Associated with Extension of the Lesions to the Lateral Margins and into the Deep Margins through the Hair Follicles in the Original Shave Removal Specimens. Dermatol Res Pract (2016) 0.75
Eleven Primary Melanomas, Colon Cancer, and Atypical Nevi in the Same Patient: A Case Report and Literature Review. Case Rep Dermatol Med (2016) 0.75
Variability in nomenclature used for nevi with architectural disorder and cytologic atypia (microscopically dysplastic nevi) by dermatologists and dermatopathologists. J Cutan Pathol (2004) 3.43
Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. Eur J Cancer (2005) 3.02
Origin of familial malignant melanomas from heritable melanocytic lesions. 'The B-K mole syndrome'. Arch Dermatol (1978) 2.81
Dermoscopy compared with naked eye examination for the diagnosis of primary melanoma: a meta-analysis of studies performed in a clinical setting. Br J Dermatol (2008) 2.67
Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma. JAMA (1997) 2.65
Genome-wide association study identifies variants at 9p21 and 22q13 associated with development of cutaneous nevi. Nat Genet (2009) 2.65
Genetics of melanoma predisposition. Oncogene (2003) 2.15
NIH Consensus conference. Diagnosis and treatment of early melanoma. JAMA (1992) 2.12
The transformation rate of moles (melanocytic nevi) into cutaneous melanoma: a population-based estimate. Arch Dermatol (2003) 2.12
Dysplastic nevus syndrome: a phenotypic association of sporadic cutaneous melanoma. Cancer (1980) 2.04
Reliability of the histopathologic diagnosis of melanocytic dysplasia. The Dysplastic Nevus Panel. Arch Dermatol (1997) 2.02
Familial atypical multiple mole-melanoma syndrome. J Med Genet (1978) 1.88
Multiple pigmentation gene polymorphisms account for a substantial proportion of risk of cutaneous malignant melanoma. J Invest Dermatol (2009) 1.81
The dysplastic nevus: from historical perspective to management in the modern era: part I. Historical, histologic, and clinical aspects. J Am Acad Dermatol (2012) 1.79
Dysplastic melanocytic nevi: a reproducible histologic definition emphasizing cellular morphology. Mod Pathol (1989) 1.71
A genome-wide scan for naevus count: linkage to CDKN2A and to other chromosome regions. Eur J Hum Genet (2006) 1.70
A multiobserver, population-based analysis of histologic dysplasia in melanocytic nevi. J Am Acad Dermatol (1994) 1.64
Dysplastic naevi: an update. Histopathology (2010) 1.57
The impact of total body photography on biopsy rate in patients from a pigmented lesion clinic. J Am Acad Dermatol (2007) 1.56
Melanoma etiology: where are we? Oncogene (2003) 1.53
A pooled analysis of melanocytic nevus phenotype and the risk of cutaneous melanoma at different latitudes. Int J Cancer (2009) 1.51
Influence of genes, nevi, and sun sensitivity on melanoma risk in a family sample unselected by family history and in melanoma-prone families. J Natl Cancer Inst (2004) 1.25
Melanoma epidemiology. Hematol Oncol Clin North Am (2009) 1.21
New cutaneous phenotype in familial malignant melanoma. Lancet (1977) 1.17
Melanoma genetics: recent findings take us beyond well-traveled pathways. J Invest Dermatol (2012) 1.16
Genetic epidemiology of cutaneous melanoma: a global perspective. Arch Dermatol (2001) 1.15
Precursor naevi in cutaneous malignant melanoma: a proposed nomenclature. Lancet (1980) 1.12
Benefits of total body photography and digital dermatoscopy ("two-step method of digital follow-up") in the early diagnosis of melanoma in patients at high risk for melanoma. J Am Acad Dermatol (2011) 1.09
A natural history of melanomas and dysplastic nevi: an atlas of lesions in melanoma-prone families. Cancer (2002) 1.05
Melanocortin-1 receptor (MC1R) gene variants and dysplastic nevi modify penetrance of CDKN2A mutations in French melanoma-prone pedigrees. Cancer Epidemiol Biomarkers Prev (2005) 1.03
Genotype/phenotype and penetrance studies in melanoma families with germline CDKN2A mutations. J Invest Dermatol (2000) 1.03
Risk of melanoma and other cancers in melanoma-prone families. J Invest Dermatol (1993) 1.02
Validity of the histopathological criteria used for diagnosing dysplastic naevi. An interobserver study by the pathology subgroup of the EORTC Malignant Melanoma Cooperative Group. Eur J Cancer (1993) 1.01
The impact of physician screening on melanoma detection. Arch Dermatol (2011) 0.91
Natural history of dysplastic nevi. J Am Acad Dermatol (1993) 0.89
Diagnosis and treatment of early melanoma. NIH Consensus Development Conference. January 27-29, 1992. Consens Statement (1992) 0.89
Inherited susceptibility to several cancers but absence of linkage between dysplastic nevus syndrome and CDKN2A in a melanoma family with a mutation in the CDKN2A (P16INK4A) gene. Hum Genet (1997) 0.88
Genome-wide linkage scan for atypical nevi in p16-Leiden melanoma families. Eur J Hum Genet (2008) 0.88
Sun-related risk factors in melanoma-prone families with CDKN2A mutations. J Natl Cancer Inst (1998) 0.86
Swedish CDKN2A mutation carriers do not present the atypical mole syndrome phenotype. Melanoma Res (2010) 0.83
Recognition and classification of clinically dysplastic nevi from photographs: a study of interobserver variation. Cancer Epidemiol Biomarkers Prev (1995) 0.83
The efficacy of histopathological criteria required for diagnosing dysplastic naevi. Histopathology (1988) 0.81
Dysplastic nevi. Dermatol Clin (2012) 0.79
Replicating genotype-phenotype associations. Nature (2007) 16.11
A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am J Hum Genet (2009) 5.62
ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma. Nat Genet (2008) 3.90
A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nat Genet (2010) 3.53
Two newly identified genetic determinants of pigmentation in Europeans. Nat Genet (2008) 3.31
The landscape of recombination in African Americans. Nature (2011) 3.06
Recent trends in incidence of cutaneous melanoma among US Caucasian young adults. J Invest Dermatol (2008) 2.80
Geographical variation in the penetrance of CDKN2A mutations for melanoma. J Natl Cancer Inst (2002) 2.70
MicroRNA expression differentiates histology and predicts survival of lung cancer. Clin Cancer Res (2010) 2.48
Cancer survivorship--genetic susceptibility and second primary cancers: research strategies and recommendations. J Natl Cancer Inst (2006) 2.42
High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL. Cancer Res (2006) 2.40
Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up. J Clin Oncol (2005) 2.37
Risk of soft tissue sarcomas by individual subtype in survivors of hereditary retinoblastoma. J Natl Cancer Inst (2007) 2.32
Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents. J Med Genet (2006) 2.17
Cancer and neurologic degeneration in xeroderma pigmentosum: long term follow-up characterises the role of DNA repair. J Med Genet (2010) 2.14
Identifying individuals at high risk of melanoma: a practical predictor of absolute risk. J Clin Oncol (2006) 2.05
Diet and melanoma in a case-control study. Cancer Epidemiol Biomarkers Prev (2004) 2.05
Gynecologic surgeries and risk of ovarian cancer in women with BRCA1 and BRCA2 Ashkenazi founder mutations: an Israeli population-based case-control study. J Natl Cancer Inst (2003) 2.04
Association of MC1R variants and risk of melanoma in melanoma-prone families with CDKN2A mutations. Cancer Epidemiol Biomarkers Prev (2005) 1.95
Melanoma induction by ultraviolet A but not ultraviolet B radiation requires melanin pigment. Nat Commun (2012) 1.90
Acral lentiginous melanoma: incidence and survival patterns in the United States, 1986-2005. Arch Dermatol (2009) 1.82
A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry. Nat Genet (2013) 1.82
Pediatric melanoma: risk factor and survival analysis of the surveillance, epidemiology and end results database. J Clin Oncol (2005) 1.77
Variation of second cancer risk by family history of retinoblastoma among long-term survivors. J Clin Oncol (2012) 1.76
Divergent cancer pathways for early-onset and late-onset cutaneous malignant melanoma. Cancer (2009) 1.71
DNA repair, dysplastic nevi, and sunlight sensitivity in the development of cutaneous malignant melanoma. J Natl Cancer Inst (2002) 1.66
Evolving risk of therapy-related acute myeloid leukemia following cancer chemotherapy among adults in the United States, 1975-2008. Blood (2013) 1.64
Increased risk of second primary cancers after a diagnosis of melanoma. Arch Dermatol (2010) 1.48
Average midrange ultraviolet radiation flux and time outdoors predict melanoma risk. Cancer Res (2002) 1.42
Cause-specific mortality in long-term survivors of retinoblastoma. J Natl Cancer Inst (2009) 1.42
Second malignancy risks after non-Hodgkin's lymphoma and chronic lymphocytic leukemia: differences by lymphoma subtype. J Clin Oncol (2010) 1.37
Selection criteria for genetic assessment of patients with familial melanoma. J Am Acad Dermatol (2009) 1.30
Genotypic variants at 2q33 and risk of esophageal squamous cell carcinoma in China: a meta-analysis of genome-wide association studies. Hum Mol Genet (2012) 1.28
Rising melanoma incidence rates of the trunk among younger women in the United States. Cancer Epidemiol Biomarkers Prev (2010) 1.27
Phase I metabolic genes and risk of lung cancer: multiple polymorphisms and mRNA expression. PLoS One (2009) 1.08
Genomewide linkage screen for Waldenstrom macroglobulinemia susceptibility loci in high-risk families. Am J Hum Genet (2006) 1.08
Genetic variants in DNA repair pathway genes and risk of esophageal squamous cell carcinoma and gastric adenocarcinoma in a Chinese population. Carcinogenesis (2013) 1.08
The chromosome 2p21 region harbors a complex genetic architecture for association with risk for renal cell carcinoma. Hum Mol Genet (2011) 1.08
Telomere length and the risk of cutaneous malignant melanoma in melanoma-prone families with and without CDKN2A mutations. PLoS One (2013) 1.07
Family history of cancer and nonmalignant lung diseases as risk factors for lung cancer. Int J Cancer (2009) 1.07
Common genetic variants related to genomic integrity and risk of papillary thyroid cancer. Carcinogenesis (2011) 1.05
Melanoma prone families with CDK4 germline mutation: phenotypic profile and associations with MC1R variants. J Med Genet (2013) 1.04
Identification of modifier genes for cutaneous malignant melanoma in melanoma-prone families with and without CDKN2A mutations. Int J Cancer (2009) 1.04
Localization of a novel melanoma susceptibility locus to 1p22. Am J Hum Genet (2003) 1.03
Breast cancer risk in Ashkenazi BRCA1/2 mutation carriers: effects of reproductive history. Epidemiology (2002) 1.02
Sarcomas in hereditary retinoblastoma. Clin Sarcoma Res (2012) 1.00
Associations of 9p21 variants with cutaneous malignant melanoma, nevi, and pigmentation phenotypes in melanoma-prone families with and without CDKN2A mutations. Fam Cancer (2010) 0.97
A mutation hotspot at the p14ARF splice site. Oncogene (2005) 0.97
A comparison of CDKN2A mutation detection within the Melanoma Genetics Consortium (GenoMEL). Eur J Cancer (2008) 0.95
Alcohol consumption and lung cancer risk in the Environment and Genetics in Lung Cancer Etiology (EAGLE) study. Am J Epidemiol (2009) 0.95
A nationwide population-based skin cancer screening in Germany: proceedings of the first meeting of the International Task Force on Skin Cancer Screening and Prevention (September 24 and 25, 2009). Cancer Epidemiol (2010) 0.93
Reproductive risk factors for cutaneous melanoma in women: a case-control study. Am J Epidemiol (2006) 0.93
Association of germline mutations in the fumarate hydratase gene and uterine fibroids in women with hereditary leiomyomatosis and renal cell cancer. Arch Dermatol (2008) 0.93
Heterogeneity of risk for melanoma and pancreatic and digestive malignancies: a melanoma case-control study. Cancer (2004) 0.92
Sunbeds and sunlamps: who used them and their risk for melanoma. Pigment Cell Melanoma Res (2011) 0.92
High-risk pregnancy and neonatal complications in the DNA repair and transcription disorder trichothiodystrophy: report of 27 affected pregnancies. Prenat Diagn (2011) 0.92
HLA-DR, HLA-DQ, and TAP genes in familial Hodgkin disease. Blood (2002) 0.91
CDKN2A point mutations D153spl(c.457G>T) and IVS2+1G>T result in aberrant splice products affecting both p16INK4a and p14ARF. Oncogene (2003) 0.90
Tobacco use in adult long-term survivors of retinoblastoma. Cancer Epidemiol Biomarkers Prev (2006) 0.89
Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. 1995. Radiat Res (2012) 0.89
The association between cancer and amyotrophic lateral sclerosis. Cancer Causes Control (2012) 0.89
Dietary quercetin, quercetin-gene interaction, metabolic gene expression in lung tissue and lung cancer risk. Carcinogenesis (2009) 0.88
Germline splicing mutations of CDKN2A predispose to melanoma. Oncogene (2003) 0.88
Cutaneous phenotype and MC1R variants as modifying factors for the development of melanoma in CDKN2A G101W mutation carriers from 4 countries. Int J Cancer (2007) 0.88
Common single nucleotide polymorphisms in genes related to immune function and risk of papillary thyroid cancer. PLoS One (2013) 0.87
On the interplay of telomeres, nevi and the risk of melanoma. PLoS One (2012) 0.87
Re: Sun exposure and mortality from melanoma. J Natl Cancer Inst (2005) 0.87
A flexible multiplex bead-based assay for detecting germline CDKN2A and CDK4 variants in melanoma-prone kindreds. J Invest Dermatol (2010) 0.87
Genetic variants in epidermal growth factor receptor pathway genes and risk of esophageal squamous cell carcinoma and gastric cancer in a Chinese population. PLoS One (2013) 0.86
Recent tanning bed use: a risk factor for melanoma. Arch Dermatol (2006) 0.86
Genetic variants in DNA repair genes and the risk of cutaneous malignant melanoma in melanoma-prone families with/without CDKN2A mutations. Int J Cancer (2011) 0.86
Lack of germline PALB2 mutations in melanoma-prone families with CDKN2A mutations and pancreatic cancer. Fam Cancer (2011) 0.86
Long-term evaluation of three multiple-case Waldenstrom macroglobulinemia families. Clin Cancer Res (2007) 0.86
Cancer screening practices of adult survivors of retinoblastoma at risk of second cancers. Cancer (2008) 0.85
Absolute risk prediction of second primary thyroid cancer among 5-year survivors of childhood cancer. J Clin Oncol (2012) 0.85
LINE-1 methylation in peripheral blood and the risk of melanoma in melanoma-prone families with and without CDKN2A mutations. Melanoma Res (2013) 0.84
Genetic variants in sex hormone metabolic pathway genes and risk of esophageal squamous cell carcinoma. Carcinogenesis (2013) 0.83
Making sense of puzzling genetic association studies: a team approach. Ann Intern Med (2006) 0.83
Genetic variants in fas signaling pathway genes and risk of gastric cancer. Int J Cancer (2013) 0.83
Hereditary genodermatoses with cancer predisposition. Hematol Oncol Clin North Am (2010) 0.83
Lack of inherited mutations of PTPRD in familial melanoma and melanoma-astrocytoma syndrome. Pigment Cell Melanoma Res (2009) 0.82
BRCA1 and sex ratio. Eur J Hum Genet (2004) 0.81
Sunscreen prevention of melanoma in man and mouse. Pigment Cell Melanoma Res (2010) 0.81
Mutation screening of CHD5 in melanoma-prone families linked to 1p36 revealed no deleterious coding or splice site changes. BMC Res Notes (2008) 0.80
The age-specific effect modification of male sex for ulcerated cutaneous melanoma. JAMA Dermatol (2014) 0.80
Breast cancer risks for BRCA1/2 carriers. Science (2004) 0.80
Effect of mutations in XPD(ERCC2) on pregnancy and prenatal development in mothers of patients with trichothiodystrophy or xeroderma pigmentosum. Eur J Hum Genet (2012) 0.80
Cytogenetics of familial Waldenstrom's macroglobulinemia: in pursuit of an understanding of genetic predisposition. Clin Lymphoma (2005) 0.80
A piece of the melanoma puzzle. J Natl Cancer Inst (2005) 0.79
Duplication of CXC chemokine genes on chromosome 4q13 in a melanoma-prone family. Pigment Cell Melanoma Res (2012) 0.79
Analysis of mutations and identification of several polymorphisms in the putative promoter region of the P34CDC2-related CDC2L1 gene located at 1P36 in melanoma cell lines and melanoma families. Int J Cancer (2002) 0.79
Epidemiology of Anorectal Melanoma in the United States: 1992 to 2011. Dermatol Surg (2016) 0.79
Genetic testing for melanoma predisposition: current challenges. Cancer Nurs (2007) 0.77
Common genetic variants in sex hormone pathway genes and papillary thyroid cancer risk. Thyroid (2012) 0.77
Re: "Childhood cancer and population mixing". Am J Epidemiol (2004) 0.77
Genetic testing for inherited predisposition to melanoma: has the time come? J Drugs Dermatol (2004) 0.76
Risk of cataract extraction among adult retinoblastoma survivors. Arch Ophthalmol (2009) 0.75
A Genome-wide Association Study of Lung Cancer Identifies a Region of Chromosome 5p15 Associated with Risk for Adenocarcinoma. Am J Hum Genet (2011) 0.75